Twitter Instagram Facebook LinkedIn YouTube  
 
Email not displaying correctly? View it in your browser.
 
Issue 1,774: September 11, 2024  
Top Stories
 
Immunize​.org Website and Clinical Resources 
 
Vaccine Information Statements
 
Featured Resources
 
Upcoming Events
 
Top Stories

“Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” links you to available 2024–25 guidance documents

Immunize​.org reviews its Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools at least monthly, prominently indicating when it was last revised. In September, Immunize​.org updated the checklist to reflect the FDA licensed/authorized 2024–25 COVID-19 mRNA vaccines (Moderna and Pfizer-BioNTech) and adjuvanted-protein vaccine (Novavax).

ACIP voted in June 2024 to recommend the use of these vaccines as licensed or authorized by FDA. Therefore, clinicians may begin using any of the 2024–25 COVID-19 vaccines as indicated by FDA as soon as they receive them.
 
Related CDC resources, including standing orders templates, are being updated, and Immunize​.org will revise the checklist as resources become available. The out-of-date 2023–24 COVID-19 vaccine resources are highlighted on the checklist as "under revision."

All COVID-19 vaccine providers should regularly review this checklist. Download the latest documents and discard outdated versions.

Related Links

Back to top
 

Immunize​.org updates key MenB resources to reflect new FDA-approved Bexsero schedule

On August 19, FDA approved a new dosing schedule for GSK meningococcal B (MenB) vaccine (Bexsero) that matches the schedule for Pfizer MenB vaccine (Trumenba). The routine 2-dose schedule requires a 6-month interval between doses. If a second dose is given earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose. Immunocompromised people and those at high risk of MenB disease should receive a 3-dose schedule with doses given at 0, 1–2, and 6-month intervals. If the second dose of a 3-dose schedule is delayed and administered 6 months or longer after the first dose, the third dose is not needed. Bexsero’s original 2-dose schedule, with a 1-month interval between the doses, is no longer licensed.

Immunize​.org is updating its MenB resources to reflect the new schedule. The first updated resources include:

     

ACIP is expected to review the new schedule at its October 2024 meeting. Questions about recipients of the previously approved 2-dose (1-month interval) Bexsero schedule are likely to be discussed. Until then, healthcare providers should refer to the updated Bexsero package insert for the currently approved schedule.

Related Links

Back to top
 
Immunize​.org posts its 2024–25 update to "Influenza: Questions and Answers"

The 2024–25 version of Immunize​.org handout Influenza: Questions and Answers is now available. It includes ACIP’s recommendation for the off-label option to use high-dose IIV or adjuvanted IIV (licensed for adults age 65 years or older) in adults age 18–64 who received a solid organ transplant and are on an immunosuppressive medication regimen, without preference over other age-appropriate influenza vaccine options. URLs were updated throughout the document.

Related Links

Back to top
 

Immunize​.org updates its clinician resource, "Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens," adding Vaxelis (DTaP-IPV-Hib-HepB) as a preferred Hib option for American Indian and Alaska Native infants

Immunize​.org updated its clinician resource, Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens:

  • Vaxelis (Merck/Sanofi), a combination DTaP-IPV-Hib-HepB vaccine, was added as a preferred option for American Indian and Alaska Native infants, in addition to PedvaxHIB (Merck)
  • Precautions about latex allergy were removed because packaging is now latex-free

Related Links


National Hispanic Heritage Month runs from September 15 to October 15; Immunize​.org’s Spanish language resources support your Spanish-speaking patients

National Hispanic Heritage Month, observed from September 15 to October 15, celebrates the histories, cultures, and contributions of Americans whose ancestors came from Spain and elsewhere in the Americas. Immunize​.org offers a variety of resources in Spanish, including translated handouts for patients and healthcare personnel and Spanish-language VISs.



Related Links

Back to top


Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico. 

¡Viva México! September 16 is the 214th anniversary of Mexico’s independence. We celebrate our neighbors by sharing select Mexican resources for vaccination information and advocacy.

Expert committees:

Advocacy groups and resources:

Helpful resources: Government institutions:

Best wishes to all our friends delivering vaccinations to the people of Mexico!


“How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early”: Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube

This week, our featured episode from the Ask the Experts Video Series is How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early. The video briefly describes what to do if the second dose of the hepatitis A vaccine is given more than 4 days before the minimum interval of 6 months after the first dose. 

The 1-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize​.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.

Back to top


Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.

Back to top
 
Immunize​.org Website and Clinical Resources

Spotlight on the website: Visit our library of short educational videos  

Immunize​.org offers more than 60 short videos for staff education, presentations, and sharing on social media. At the “Clinical Resources” tab on the menu bar at the top of every page, select “Webinars & Videos” from the bottom of the left menu. 



From the “Webinars & Videos” home page, choose the option to view available “Videos” by clicking on the folder tab.



Narrow your search by filtering videos to one of four “Subjects” (categories) available: 

Orientation Video Series: These 3–4-minute videos introduce you to our organization and its mission, and guide viewers through the most popular sections of our website. Videos are available in a landscape view showing how the website looks on a desktop computer or a vertical “mobile view” that demonstrates the navigation of Immunize​.org on a smartphone.

 Ask the Experts Video Series: These 1–3-minute videos answer diverse clinical questions taken from our popular Ask the Experts web section. These videos can also be accessed through the Ask the Experts web section. 

Improving the Vaccination Experience Video Series: These 3–4-minute videos provide healthcare providers and vaccine recipients or caregivers with science-based methods to reduce pain and anxiety during vaccination visits. These resources address the needs of anxious children and adults.

Partner videos: These provide vaccine information from our trusted partners, such as the Vanderbilt Kennedy Center for Excellence, Vaccine Education Center of the Children’s Hospital of Philadelphia, and CDC.

Related Links

Back to top
 
Recap: Immunize​.org updates “Ask the Experts: RSV (Respiratory Syncytial Virus)” web section for the 2024–25 season 

Immunize​.org updated its popular Ask the Experts: RSV (Respiratory Syncytial Virus) web page to reflect the 2024 ACIP recommendations for RSV vaccination of older adults and the mRNA vaccine (mResvia, Moderna). The content now addresses the updated ACIP recommendations for older adults, including the routine recommendation for one dose of RSV vaccine for all adults age 75 years or older and the recommendation for one dose of RSV vaccine for adults age 60 through 74 who are at increased risk of severe RSV disease.

Immunize​.org’s Ask the Experts main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize​.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MPH.

Related Link

  • Immunize​.org: Ask the Experts main page with more than 1,300 questions and answers

Recap: Immunize​.org updates “Vaccinations for Adults: You’re Never Too Old to Get Vaccinated!” handout with current pneumococcal and RSV recommendations

Immunize​.org updated its Vaccinations for Adults: You’re Never Too Old to Get Vaccinated! This handout now includes the updated recommendations for routine RSV vaccination of adults age 75 years and older, as well as risk-based recommendations for adults age 60–74 years. Information on pneumococcal vaccines was reworded for greater clarity.

Related Links

Back to top


Recap: Immunize​.org updates the Spanish translations of 2024–25 screening checklists for contraindications to injectable and nasal influenza vaccines

Immunize​.org updated its Spanish translations of screening checklists for the 2024–25 influenza season.

References to the number of influenza virus strains in the vaccines were removed because all vaccines for this season contain three strains, two influenza A and one influenza B strain. The B/Yamagata strain is no longer included because it is not detected anywhere in the world.

      

Related Links


Summary: These updated Immunize​.org educational materials for clinicians were released during July and August

IZ Express regularly provides readers with information about Immunize​.org’s new and updated web pages, educational materials for healthcare professionals, and patient handouts. All Immunize​.org clinical resources are free to distribute. 

Immunize​.org Materials for Clinicians 

Immunize​.org Materials for Patients 

Web Pages 


Vaccine Information Statements

Summary: These new VIS translations were posted in August 

IZ Express regularly provides readers with information about VISs and translations of VISs. Vanderburgh County (Indiana) Health Department generously donated seven Marshallese VIS translations, shown below. 

Related Links 

Back to top

Featured Resources

Mighty handy! Immunize​.org offers adult and lifetime handheld immunization record cards you can provide your patients. 

Immunize​.org's personal immunization record cards, printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.

Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected].

Related Links

Back to top

Upcoming Events

Virtual: North Dakota State University hosts webinar titled “Vaccines under the Microscope: How Can We Know They Are Safe?" on September 19 and 20 at 1:00 p.m. (ET) and archived webinars; CE credit available

North Dakota State University's Center for Immunization Research and Education (CIRE) will host a webinar titled Vaccines under the Microscope: How Can We Know They Are Safe?, 1:00–2:00 p.m. (ET) on September 19 and 20. The webinar will review U.S. vaccine safety surveillance systems and discuss how safety is prioritized during vaccine development and licensing.

Free CE will be provided for this activity.

Register for the webinar.



CIRE now offers free access to recordings of its monthly webinars on its website. Participants who watch the full recording and complete the pre- and post-training quizzes may earn free CE credit for each webinar.

Learn more about CE opportunities

Back to top


Virtual: WHO hosts webinar titled “Inequality in Immunization 2024” on September 24 at 7:00 a.m. (ET)

The World Health Organization (WHO) will hold a webinar titled Inequality in Immunization 2024 at 7:00 a.m. (ET) on September 24. It will feature video contributions from the authors and editors of the Vaccines 2024 special issue on "Inequality in Immunization." The special issue emphasizes research and review articles that deepen our understanding of immunization inequalities. The table of contents for the 2024 special issue appears here. The 2023 special issue from that same journal is archived here.

Register for the webinar.

Related Links

Back to top

Virtual: CDC hosts webinar titled “Vaccinations for School-Age Children: An Opportunity for Health Promotion, Collaboration, and Family Engagement!” on September 25 at 3:00 p.m. (ET); CE credit available

CDC, U.S. Department of Education, National Association of School Nurses, and Alliance for a Healthier Generation will host a webinar titled Vaccinations for School-Age Children: Opportunities for Health Promotion, Collaboration, and Family Engagement!, 3:00–4:30 p.m. (ET) on September 25. This webinar will provide school and healthcare attendees with training on the latest ACIP vaccination recommendations for K-12 students, and evidence-based strategies for strengthening childhood vaccination coverage. There will also be tips for how to develop partnership opportunities and use resources to talk with families about the importance of childhood vaccination.

The training will be recorded and available on CDC TRAIN for 1 year.

Continuing education credits for this activity are pending.

Register for the webinar.
 
 
For more upcoming events, visit our Calendar of Events.
Editorial Information

Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
 
About IZ Express
Immunize​.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize​.org is the source of the material and provide a link to this issue.

IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize​.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN: 2771-8085






This email was sent to [email protected]
why did I get this?    unsubscribe from this list    update subscription preferences
Immunize.org · 2136 Ford Parkway · Suite 5011 · Saint Paul, MN 55116 · USA